Results 191 to 200 of about 2,533,954 (307)

Mitophagy Balance in Various Cell Subsets in Patients with ANCA-Associated Vasculitis and Correlation with the Presence of Anti-Neutrophil Cytoplasmic Antibodies. [PDF]

Mediterr J Rheumatol, 2020
Banos A, Thomas K, Garantziotis P, Malissovas N, Filia A, Pieta A, Nikolopoulos D, Moustafa S, Panagiotopoulos A, Boumpas DT, Vassilopoulos D.   +10 more
europepmc   +1 more source

Ectopic Relapse of Anti-neutrophil Cytoplasmic Antibody-associated Pituitary Vasculitis with No Elevation of Anti-neutrophil Cytoplasmic Antibodies after Renal Remission. [PDF]

Intern Med, 2020
Muto R, Inagaki K, Sato N, Sameshima T, Nagakura Y, Baba S, Kato N, Maruyama S, Akahori T.   +8 more
europepmc   +1 more source

Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis

Background: Up to 12% of patients with systemic sclerosis (SSc) have anti-neutrophil cytoplasmic antibodies (ANCA). However, the majority of these patients do not manifest ANCA-associated vasculitis (AAV) and the significance of ANCA in these patients is
Susanna Proudman (838581), Gabor Major (21132833), Joanne Sahhar (3819268), Jenny Walker (440095), Michelle Wilson (421995), Wendy Stevens (62288), Mandana Nikpour (838582), Jayne Moxey (21316766), Molla Huq (3403175), Gemma Strickland (21304214), Laura Ross (591216), Gene-Siew Ngian (4064890), Janet Roddy (8055470)   +12 more
core  

Transfersomes with core and surface‐loaded NF‐κB p65 siRNA for enhanced transdermal transfection and effective treatment of psoriasis

BMEMat, EarlyView.
TCPL, a transfersome with Tween 80 and PEI, enables efficient transdermal siNF‐κB delivery, resolving PEI's toxicity issue. It promotes lysosomal escape and effective transfection, silences NF‐κB, modulates immunity, and inhibits angiogenesis, alleviating psoriasis. With good biocompatibility, TCPL holds strong clinical translation potential. Schematic
Hui Xing, Yuhui Yang, Ziyi Zhao, Kai Lv, Yiran Shao, Zhi Zhang, Dong Ma   +6 more
wiley   +1 more source

Neutrophils from vasculitis patients exhibit an increased propensity for activation by anti‐neutrophil cytoplasmic antibodies

Clinical and Experimental Immunology, 2014
S. Ohlsson, Sophie Ohlsson, D. Söderberg, L. Gunnarsson, Å. Pettersson, M. Segelmark, T. Hellmark   +6 more
semanticscholar   +1 more source

Proteinase 3 (PR3)-Positive Perinuclear Anti-neutrophil Cytoplasmic Antibodies (pANCA) Vasculitis With Concurrent Invasive Aspergillosis Infection. [PDF]

Cureus
Smith D, Herminie V, Priya S, Shehata MZA.   +3 more
europepmc   +1 more source

Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients. [PDF]

Front Immunol, 2020
van Dam LS, Oskam JM, Kamerling SWA, Arends EJ, Bredewold OW, Berkowska MA, van Dongen JJM, Rabelink TJ, van Kooten C, Teng YKO.   +9 more
europepmc   +1 more source

Nanomedicine‐driven innovations in postoperative cancer immunotherapy: Remodeling tumor microenvironment and precision delivery strategies

BMEMat, EarlyView.
Nanomedicine‐Driven Strategies for Suppressing Postoperative Tumor Recurrence. This schematic illustrates three pivotal nanomedical strategies that synergistically counteract recurrence by targeting residual disease and the immunosuppressive tumor microenvironment within the surgical cavity.
Lisong Pang, Zhuomin Wang, Zhenhua Jin, Ahmed H. Ghonaim, Hengcheng Zhang, Xinyu You, Jinzhuo Ning, Jiaqing Cao, Yang Liu   +8 more
wiley   +1 more source

Bilateral Choroidal Detachments Associated with Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (P-ANCA) - Associated Vasculitis. [PDF]

Ocul Immunol Inflamm
Ötleş E, Serbest Ceylanoglu K, Demirci H.   +2 more
europepmc   +1 more source

Electron compensation‐gated nanomotor for immunomodulation and microenvironment remodeling in bacterial pneumonia therapy

BMEMat, EarlyView.
A nanomotor featuring an “electronic lock” via electron compensation in an Au‐Ag alloy ensures therapeutic precision. Near‐infrared light acts as a key, unlocking on‐demand Ag+ release for synergistic bactericidal action and microenvironment remodeling to potently treat bacterial pneumonia. Abstract Bacterial pneumonia treatment is severely hampered by
Chenglong Xue, Xiaoyu Zhao, Yuqian Wang, Lijin Shi, Qi Shuai   +4 more
wiley   +1 more source